Analysis | Metabolite Name | Measured Value | Units | CASE_CONTROL | Chemotherapy | Drug | Race | TIMEPOINT | Tamoxyfen | Taxane |
---|---|---|---|---|---|---|---|---|---|---|
Reversed phase POSITIVE ION MODE | SEROTONIN (CAS# 50-67-9); (M+H)+ | 1346 | Peak area | Control | Y | Exemestane | White | Baseline | Y | N |
Reversed phase POSITIVE ION MODE | SEROTONIN (CAS# 50-67-9); (M+H)+ | 1849 | Peak area | Case | N | Exemestane | White | Baseline | Y | N |
Reversed phase POSITIVE ION MODE | SEROTONIN (CAS# 50-67-9); (M+H)+ | 1869 | Peak area | Control | N | Letrozole | Black | Baseline | N | N |
Reversed phase POSITIVE ION MODE | SEROTONIN (CAS# 50-67-9); (M+H)+ | 1983 | Peak area | Control | Y | Exemestane | White | 3 Month | Y | N |
Reversed phase POSITIVE ION MODE | SEROTONIN (CAS# 50-67-9); (M+H)+ | 3026 | Peak area | Control | Y | Exemestane | White | Baseline | N | Y |
Reversed phase POSITIVE ION MODE | SEROTONIN (CAS# 50-67-9); (M+H)+ | 3327 | Peak area | Control | N | Exemestane | White | Baseline | N | N |
Reversed phase POSITIVE ION MODE | SEROTONIN (CAS# 50-67-9); (M+H)+ | 4389 | Peak area | Control | Y | Exemestane | White | 3 Month | N | Y |
Reversed phase POSITIVE ION MODE | SEROTONIN (CAS# 50-67-9); (M+H)+ | 5093 | Peak area | Case | N | Letrozole | White | 3 Month | Y | N |
Reversed phase POSITIVE ION MODE | SEROTONIN (CAS# 50-67-9); (M+H)+ | 5120 | Peak area | Control | N | Letrozole | Black | 3 Month | N | N |
Reversed phase POSITIVE ION MODE | SEROTONIN (CAS# 50-67-9); (M+H)+ | 5465 | Peak area | Control | N | Letrozole | White | 3 Month | N | N |
Reversed phase POSITIVE ION MODE | SEROTONIN (CAS# 50-67-9); (M+H)+ | 5924 | Peak area | Case | Y | Letrozole | White | Baseline | Y | Y |
Reversed phase POSITIVE ION MODE | SEROTONIN (CAS# 50-67-9); (M+H)+ | 6358 | Peak area | Case | Y | Letrozole | White | 3 Month | Y | Y |
Reversed phase POSITIVE ION MODE | SEROTONIN (CAS# 50-67-9); (M+H)+ | 7223 | Peak area | Case | Y | Letrozole | White | 3 Month | Y | Y |
Reversed phase POSITIVE ION MODE | SEROTONIN (CAS# 50-67-9); (M+H)+ | 7673 | Peak area | Case | N | Exemestane | White | 3 Month | Y | N |
Reversed phase POSITIVE ION MODE | SEROTONIN (CAS# 50-67-9); (M+H)+ | 7974 | Peak area | Case | N | Letrozole | White | Baseline | Y | N |
Reversed phase POSITIVE ION MODE | SEROTONIN (CAS# 50-67-9); (M+H)+ | 8214 | Peak area | Control | N | Letrozole | White | Baseline | Y | N |
Reversed phase POSITIVE ION MODE | SEROTONIN (CAS# 50-67-9); (M+H)+ | 8509 | Peak area | Control | N | Letrozole | White | 3 Month | Y | N |
Reversed phase POSITIVE ION MODE | SEROTONIN (CAS# 50-67-9); (M+H)+ | 8844 | Peak area | Case | N | Exemestane | White | Baseline | N | N |
Reversed phase POSITIVE ION MODE | SEROTONIN (CAS# 50-67-9); (M+H)+ | 9853 | Peak area | Case | N | Letrozole | White | Baseline | Y | N |
Reversed phase POSITIVE ION MODE | SEROTONIN (CAS# 50-67-9); (M+H)+ | 10084 | Peak area | Case | N | Letrozole | White | Baseline | N | N |
Reversed phase POSITIVE ION MODE | SEROTONIN (CAS# 50-67-9); (M+H)+ | 11122 | Peak area | Case | Y | Exemestane | White | 3 Month | N | Y |
Reversed phase POSITIVE ION MODE | SEROTONIN (CAS# 50-67-9); (M+H)+ | 12518 | Peak area | Control | N | Exemestane | Black | 3 Month | Y | N |
Reversed phase POSITIVE ION MODE | SEROTONIN (CAS# 50-67-9); (M+H)+ | 12664 | Peak area | Case | N | Exemestane | White | 3 Month | N | N |
Reversed phase POSITIVE ION MODE | SEROTONIN (CAS# 50-67-9); (M+H)+ | 12852 | Peak area | Case | Y | Letrozole | White | Baseline | Y | Y |
Reversed phase POSITIVE ION MODE | SEROTONIN (CAS# 50-67-9); (M+H)+ | 13534 | Peak area | Control | Y | Exemestane | White | Baseline | N | N |
Reversed phase POSITIVE ION MODE | SEROTONIN (CAS# 50-67-9); (M+H)+ | 14535 | Peak area | Control | Y | Exemestane | White | Baseline | Y | N |
Reversed phase POSITIVE ION MODE | SEROTONIN (CAS# 50-67-9); (M+H)+ | 15756 | Peak area | Case | N | Letrozole | Black | 3 Month | N | N |
Reversed phase POSITIVE ION MODE | SEROTONIN (CAS# 50-67-9); (M+H)+ | 15905 | Peak area | Control | Y | Letrozole | White | Baseline | Y | Y |
Reversed phase POSITIVE ION MODE | SEROTONIN (CAS# 50-67-9); (M+H)+ | 17538 | Peak area | Case | N | Letrozole | White | 3 Month | N | N |
Reversed phase POSITIVE ION MODE | SEROTONIN (CAS# 50-67-9); (M+H)+ | 17747 | Peak area | Case | Y | Exemestane | White | Baseline | Y | N |
Reversed phase POSITIVE ION MODE | SEROTONIN (CAS# 50-67-9); (M+H)+ | 17748 | Peak area | Case | Y | Exemestane | White | 3 Month | Y | N |
Reversed phase POSITIVE ION MODE | SEROTONIN (CAS# 50-67-9); (M+H)+ | 18446 | Peak area | Case | N | Exemestane | White | Baseline | N | N |
Reversed phase POSITIVE ION MODE | SEROTONIN (CAS# 50-67-9); (M+H)+ | 18534 | Peak area | Case | N | Exemestane | White | 3 Month | N | N |
Reversed phase POSITIVE ION MODE | SEROTONIN (CAS# 50-67-9); (M+H)+ | 18907 | Peak area | Case | N | Letrozole | Black | Baseline | N | N |
Reversed phase POSITIVE ION MODE | SEROTONIN (CAS# 50-67-9); (M+H)+ | 19068 | Peak area | Case | Y | Exemestane | White | 3 Month | N | Y |
Reversed phase POSITIVE ION MODE | SEROTONIN (CAS# 50-67-9); (M+H)+ | 19237 | Peak area | Case | Y | Exemestane | White | 3 Month | N | Y |
Reversed phase POSITIVE ION MODE | SEROTONIN (CAS# 50-67-9); (M+H)+ | 19561 | Peak area | Case | Y | Letrozole | White | 3 Month | Y | Y |
Reversed phase POSITIVE ION MODE | SEROTONIN (CAS# 50-67-9); (M+H)+ | 20042 | Peak area | Case | Y | Letrozole | White | Baseline | Y | Y |
Reversed phase POSITIVE ION MODE | SEROTONIN (CAS# 50-67-9); (M+H)+ | 21048 | Peak area | Case | N | Letrozole | White | 3 Month | Y | N |
Reversed phase POSITIVE ION MODE | SEROTONIN (CAS# 50-67-9); (M+H)+ | 21325 | Peak area | Case | N | Letrozole | White | Baseline | N | N |
Reversed phase POSITIVE ION MODE | SEROTONIN (CAS# 50-67-9); (M+H)+ | 21521 | Peak area | Control | Y | Exemestane | White | Baseline | N | Y |
Reversed phase POSITIVE ION MODE | SEROTONIN (CAS# 50-67-9); (M+H)+ | 22991 | Peak area | Case | N | Letrozole | White | 3 Month | Y | N |
Reversed phase POSITIVE ION MODE | SEROTONIN (CAS# 50-67-9); (M+H)+ | 23169 | Peak area | Case | Y | Exemestane | White | Baseline | N | Y |
Reversed phase POSITIVE ION MODE | SEROTONIN (CAS# 50-67-9); (M+H)+ | 24966 | Peak area | Control | Y | Exemestane | White | Baseline | N | N |
Reversed phase POSITIVE ION MODE | SEROTONIN (CAS# 50-67-9); (M+H)+ | 25906 | Peak area | Control | Y | Exemestane | White | 3 Month | N | Y |
Reversed phase POSITIVE ION MODE | SEROTONIN (CAS# 50-67-9); (M+H)+ | 26296 | Peak area | Control | Y | Letrozole | White | Baseline | Y | N |
Reversed phase POSITIVE ION MODE | SEROTONIN (CAS# 50-67-9); (M+H)+ | 26721 | Peak area | Control | N | Letrozole | White | 3 Month | N | N |
Reversed phase POSITIVE ION MODE | SEROTONIN (CAS# 50-67-9); (M+H)+ | 27427 | Peak area | Control | N | Letrozole | White | Baseline | N | N |
Reversed phase POSITIVE ION MODE | SEROTONIN (CAS# 50-67-9); (M+H)+ | 27547 | Peak area | Control | Y | Letrozole | White | 3 Month | Y | Y |
Reversed phase POSITIVE ION MODE | SEROTONIN (CAS# 50-67-9); (M+H)+ | 30230 | Peak area | Control | Y | Letrozole | White | 3 Month | Y | N |
Reversed phase POSITIVE ION MODE | SEROTONIN (CAS# 50-67-9); (M+H)+ | 30237 | Peak area | Case | Y | Exemestane | White | Baseline | Y | Y |
Reversed phase POSITIVE ION MODE | SEROTONIN (CAS# 50-67-9); (M+H)+ | 31407 | Peak area | Control | Y | Exemestane | White | 3 Month | Y | N |
Reversed phase POSITIVE ION MODE | SEROTONIN (CAS# 50-67-9); (M+H)+ | 31467 | Peak area | Control | N | Exemestane | White | Baseline | N | N |
Reversed phase POSITIVE ION MODE | SEROTONIN (CAS# 50-67-9); (M+H)+ | 31468 | Peak area | Case | N | Letrozole | White | Baseline | Y | N |
Reversed phase POSITIVE ION MODE | SEROTONIN (CAS# 50-67-9); (M+H)+ | 31499 | Peak area | Control | Y | Exemestane | White | Baseline | Y | N |
Reversed phase POSITIVE ION MODE | SEROTONIN (CAS# 50-67-9); (M+H)+ | 31662 | Peak area | Control | N | Exemestane | White | 3 Month | N | N |
Reversed phase POSITIVE ION MODE | SEROTONIN (CAS# 50-67-9); (M+H)+ | 31947 | Peak area | Case | N | Exemestane | White | 3 Month | N | N |
Reversed phase POSITIVE ION MODE | SEROTONIN (CAS# 50-67-9); (M+H)+ | 31999 | Peak area | Control | Y | Exemestane | White | 3 Month | N | N |
Reversed phase POSITIVE ION MODE | SEROTONIN (CAS# 50-67-9); (M+H)+ | 32081 | Peak area | Control | Y | Exemestane | White | 3 Month | N | N |
Reversed phase POSITIVE ION MODE | SEROTONIN (CAS# 50-67-9); (M+H)+ | 35395 | Peak area | Case | Y | Exemestane | White | Baseline | N | Y |
Reversed phase POSITIVE ION MODE | SEROTONIN (CAS# 50-67-9); (M+H)+ | 35846 | Peak area | Case | Y | Exemestane | White | Baseline | Y | Y |
Reversed phase POSITIVE ION MODE | SEROTONIN (CAS# 50-67-9); (M+H)+ | 36359 | Peak area | Control | N | Exemestane | White | Baseline | N | N |
Reversed phase POSITIVE ION MODE | SEROTONIN (CAS# 50-67-9); (M+H)+ | 36685 | Peak area | Case | Y | Exemestane | White | 3 Month | Y | Y |
Reversed phase POSITIVE ION MODE | SEROTONIN (CAS# 50-67-9); (M+H)+ | 41989 | Peak area | Case | N | Exemestane | White | Baseline | N | N |
Reversed phase POSITIVE ION MODE | SEROTONIN (CAS# 50-67-9); (M+H)+ | 44200 | Peak area | Control | N | Exemestane | White | 3 Month | N | N |
Reversed phase POSITIVE ION MODE | SEROTONIN (CAS# 50-67-9); (M+H)+ | 45003 | Peak area | Control | N | Exemestane | White | Baseline | Y | N |
Reversed phase POSITIVE ION MODE | SEROTONIN (CAS# 50-67-9); (M+H)+ | 46826 | Peak area | Case | Y | Exemestane | White | 3 Month | Y | Y |
Reversed phase POSITIVE ION MODE | SEROTONIN (CAS# 50-67-9); (M+H)+ | 47375 | Peak area | Control | N | Letrozole | White | Baseline | Y | N |
Reversed phase POSITIVE ION MODE | SEROTONIN (CAS# 50-67-9); (M+H)+ | 49014 | Peak area | Control | N | Exemestane | White | 3 Month | N | N |
Reversed phase POSITIVE ION MODE | SEROTONIN (CAS# 50-67-9); (M+H)+ | 49330 | Peak area | Case | N | Exemestane | White | Baseline | Y | N |
Reversed phase POSITIVE ION MODE | SEROTONIN (CAS# 50-67-9); (M+H)+ | 49503 | Peak area | Case | N | Exemestane | White | 3 Month | Y | N |
Reversed phase POSITIVE ION MODE | SEROTONIN (CAS# 50-67-9); (M+H)+ | 49629 | Peak area | Control | N | Exemestane | White | Baseline | N | N |
Reversed phase POSITIVE ION MODE | SEROTONIN (CAS# 50-67-9); (M+H)+ | 50864 | Peak area | Control | Y | Exemestane | White | Baseline | Y | Y |
Reversed phase POSITIVE ION MODE | SEROTONIN (CAS# 50-67-9); (M+H)+ | 51224 | Peak area | Control | Y | Exemestane | White | 3 Month | Y | Y |
Reversed phase POSITIVE ION MODE | SEROTONIN (CAS# 50-67-9); (M+H)+ | 51679 | Peak area | Control | N | Exemestane | White | 3 Month | Y | N |
Reversed phase POSITIVE ION MODE | SEROTONIN (CAS# 50-67-9); (M+H)+ | 53276 | Peak area | Case | N | Exemestane | White | Baseline | Y | N |
Reversed phase POSITIVE ION MODE | SEROTONIN (CAS# 50-67-9); (M+H)+ | 54112 | Peak area | Case | N | Exemestane | Black | 3 Month | N | N |
Reversed phase POSITIVE ION MODE | SEROTONIN (CAS# 50-67-9); (M+H)+ | 54795 | Peak area | Control | N | Exemestane | White | 3 Month | N | N |
Reversed phase POSITIVE ION MODE | SEROTONIN (CAS# 50-67-9); (M+H)+ | 60422 | Peak area | Case | Y | Exemestane | White | Baseline | N | Y |
Reversed phase POSITIVE ION MODE | SEROTONIN (CAS# 50-67-9); (M+H)+ | 61825 | Peak area | Control | N | Exemestane | Black | Baseline | Y | N |
Reversed phase POSITIVE ION MODE | SEROTONIN (CAS# 50-67-9); (M+H)+ | 65827 | Peak area | Case | Y | Exemestane | White | Baseline | N | Y |
Reversed phase POSITIVE ION MODE | SEROTONIN (CAS# 50-67-9); (M+H)+ | 72365 | Peak area | Control | N | Letrozole | White | 3 Month | Y | N |
Reversed phase POSITIVE ION MODE | SEROTONIN (CAS# 50-67-9); (M+H)+ | 95874 | Peak area | Case | N | Exemestane | White | 3 Month | Y | N |
Reversed phase POSITIVE ION MODE | SEROTONIN (CAS# 50-67-9); (M+H)+ | 100627 | Peak area | Case | Y | Exemestane | White | 3 Month | N | Y |
Reversed phase POSITIVE ION MODE | SEROTONIN (CAS# 50-67-9); (M+H)+ | 104135 | Peak area | Case | N | Exemestane | Black | Baseline | N | N |
Reversed phase POSITIVE ION MODE | SEROTONIN (CAS# 50-67-9); (M+H)+ | 130853 | Peak area | Case | Y | Exemestane | White | Baseline | Y | N |
Reversed phase POSITIVE ION MODE | SEROTONIN (CAS# 50-67-9); (M+H)+ | 234808 | Peak area | Case | Y | Exemestane | White | 3 Month | Y | N |
Reversed phase POSITIVE ION MODE | SEROTONIN (CAS# 50-67-9); (M+H)+ | 489828 | Peak area | Control | N | Letrozole | White | 3 Month | Y | N |
Reversed phase POSITIVE ION MODE | SEROTONIN (CAS# 50-67-9); (M+H)+ | 494333 | Peak area | Case | Y | Exemestane | Black | Baseline | N | Y |
Reversed phase POSITIVE ION MODE | SEROTONIN (CAS# 50-67-9); (M+H)+ | 531929 | Peak area | Control | N | Letrozole | White | Baseline | Y | N |
Reversed phase POSITIVE ION MODE | SEROTONIN (CAS# 50-67-9); (M+H)+ | 573038 | Peak area | Case | Y | Exemestane | Black | 3 Month | N | Y |
Reversed phase POSITIVE ION MODE | SEROTONIN (CAS# 50-67-9); (M+H)+ | Peak area | Case | N | Letrozole | White | 3 Month | N | N | |
Reversed phase POSITIVE ION MODE | SEROTONIN (CAS# 50-67-9); (M+H)+ | Peak area | Control | N | Exemestane | White | 3 Month | N | N | |
Reversed phase POSITIVE ION MODE | SEROTONIN (CAS# 50-67-9); (M+H)+ | Peak area | Control | N | Exemestane | White | Baseline | N | N | |
Reversed phase POSITIVE ION MODE | SEROTONIN (CAS# 50-67-9); (M+H)+ | Peak area | Control | N | Letrozole | White | 3 Month | N | N | |
Reversed phase POSITIVE ION MODE | SEROTONIN (CAS# 50-67-9); (M+H)+ | Peak area | Control | N | Letrozole | White | Baseline | N | N | |
Reversed phase POSITIVE ION MODE | SEROTONIN (CAS# 50-67-9); (M+H)+ | Peak area | Control | Y | Exemestane | White | 3 Month | Y | N | |
Reversed phase POSITIVE ION MODE | SEROTONIN (CAS# 50-67-9); (M+H)+ | Peak area | Control | Y | Letrozole | White | 3 Month | Y | Y | |
Reversed phase POSITIVE ION MODE | SEROTONIN (CAS# 50-67-9); (M+H)+ | Peak area | Control | Y | Letrozole | White | Baseline | Y | Y | |
Reversed phase POSITIVE ION MODE | SEROTONIN (CAS# 50-67-9); (M+NA)+ | 5335 | Peak area | Case | Y | Exemestane | White | Baseline | N | Y |
Reversed phase POSITIVE ION MODE | SEROTONIN (CAS# 50-67-9); (M+NA)+ | 6038 | Peak area | Case | N | Letrozole | Black | 3 Month | N | N |
Reversed phase POSITIVE ION MODE | SEROTONIN (CAS# 50-67-9); (M+NA)+ | 8403 | Peak area | Control | N | Letrozole | White | 3 Month | Y | N |
Reversed phase POSITIVE ION MODE | SEROTONIN (CAS# 50-67-9); (M+NA)+ | 8956 | Peak area | Control | N | Letrozole | White | Baseline | N | N |
Reversed phase POSITIVE ION MODE | SEROTONIN (CAS# 50-67-9); (M+NA)+ | 9219 | Peak area | Case | N | Exemestane | White | 3 Month | N | N |
Reversed phase POSITIVE ION MODE | SEROTONIN (CAS# 50-67-9); (M+NA)+ | 9443 | Peak area | Control | Y | Exemestane | White | 3 Month | Y | N |
Reversed phase POSITIVE ION MODE | SEROTONIN (CAS# 50-67-9); (M+NA)+ | 9519 | Peak area | Case | Y | Exemestane | White | Baseline | Y | N |
Reversed phase POSITIVE ION MODE | SEROTONIN (CAS# 50-67-9); (M+NA)+ | 11639 | Peak area | Control | Y | Exemestane | White | Baseline | Y | N |
Reversed phase POSITIVE ION MODE | SEROTONIN (CAS# 50-67-9); (M+NA)+ | 12815 | Peak area | Control | N | Exemestane | White | 3 Month | N | N |
Reversed phase POSITIVE ION MODE | SEROTONIN (CAS# 50-67-9); (M+NA)+ | 13624 | Peak area | Control | Y | Exemestane | White | Baseline | N | N |
Reversed phase POSITIVE ION MODE | SEROTONIN (CAS# 50-67-9); (M+NA)+ | 13763 | Peak area | Control | Y | Letrozole | White | 3 Month | Y | Y |
Reversed phase POSITIVE ION MODE | SEROTONIN (CAS# 50-67-9); (M+NA)+ | 16907 | Peak area | Case | N | Exemestane | White | 3 Month | N | N |
Reversed phase POSITIVE ION MODE | SEROTONIN (CAS# 50-67-9); (M+NA)+ | 17052 | Peak area | Control | N | Letrozole | White | 3 Month | N | N |
Reversed phase POSITIVE ION MODE | SEROTONIN (CAS# 50-67-9); (M+NA)+ | 17202 | Peak area | Case | Y | Exemestane | White | 3 Month | N | Y |
Reversed phase POSITIVE ION MODE | SEROTONIN (CAS# 50-67-9); (M+NA)+ | 21544 | Peak area | Case | N | Exemestane | Black | Baseline | N | N |
Reversed phase POSITIVE ION MODE | SEROTONIN (CAS# 50-67-9); (M+NA)+ | 23318 | Peak area | Case | Y | Exemestane | White | Baseline | Y | N |
Reversed phase POSITIVE ION MODE | SEROTONIN (CAS# 50-67-9); (M+NA)+ | 32275 | Peak area | Case | Y | Exemestane | White | 3 Month | Y | N |
Reversed phase POSITIVE ION MODE | SEROTONIN (CAS# 50-67-9); (M+NA)+ | 33024 | Peak area | Case | N | Exemestane | Black | 3 Month | N | N |
Reversed phase POSITIVE ION MODE | SEROTONIN (CAS# 50-67-9); (M+NA)+ | 38995 | Peak area | Control | N | Letrozole | White | 3 Month | N | N |
Reversed phase POSITIVE ION MODE | SEROTONIN (CAS# 50-67-9); (M+NA)+ | 57781 | Peak area | Control | N | Letrozole | White | Baseline | Y | N |
Reversed phase POSITIVE ION MODE | SEROTONIN (CAS# 50-67-9); (M+NA)+ | 62893 | Peak area | Case | Y | Exemestane | Black | Baseline | N | Y |
Reversed phase POSITIVE ION MODE | SEROTONIN (CAS# 50-67-9); (M+NA)+ | 73304 | Peak area | Control | N | Letrozole | White | 3 Month | Y | N |
Reversed phase POSITIVE ION MODE | SEROTONIN (CAS# 50-67-9); (M+NA)+ | 81666 | Peak area | Case | Y | Exemestane | Black | 3 Month | N | Y |
Reversed phase POSITIVE ION MODE | SEROTONIN (CAS# 50-67-9); (M+NA)+ | Peak area | Case | N | Exemestane | White | 3 Month | N | N | |
Reversed phase POSITIVE ION MODE | SEROTONIN (CAS# 50-67-9); (M+NA)+ | Peak area | Case | N | Exemestane | White | 3 Month | Y | N | |
Reversed phase POSITIVE ION MODE | SEROTONIN (CAS# 50-67-9); (M+NA)+ | Peak area | Case | N | Exemestane | White | Baseline | N | N | |
Reversed phase POSITIVE ION MODE | SEROTONIN (CAS# 50-67-9); (M+NA)+ | Peak area | Case | N | Exemestane | White | Baseline | Y | N | |
Reversed phase POSITIVE ION MODE | SEROTONIN (CAS# 50-67-9); (M+NA)+ | Peak area | Case | N | Letrozole | Black | Baseline | N | N | |
Reversed phase POSITIVE ION MODE | SEROTONIN (CAS# 50-67-9); (M+NA)+ | Peak area | Case | N | Letrozole | White | 3 Month | N | N | |
Reversed phase POSITIVE ION MODE | SEROTONIN (CAS# 50-67-9); (M+NA)+ | Peak area | Case | N | Letrozole | White | 3 Month | Y | N | |
Reversed phase POSITIVE ION MODE | SEROTONIN (CAS# 50-67-9); (M+NA)+ | Peak area | Case | N | Letrozole | White | Baseline | N | N | |
Reversed phase POSITIVE ION MODE | SEROTONIN (CAS# 50-67-9); (M+NA)+ | Peak area | Case | N | Letrozole | White | Baseline | Y | N | |
Reversed phase POSITIVE ION MODE | SEROTONIN (CAS# 50-67-9); (M+NA)+ | Peak area | Case | Y | Exemestane | White | 3 Month | N | Y | |
Reversed phase POSITIVE ION MODE | SEROTONIN (CAS# 50-67-9); (M+NA)+ | Peak area | Case | Y | Exemestane | White | 3 Month | Y | N | |
Reversed phase POSITIVE ION MODE | SEROTONIN (CAS# 50-67-9); (M+NA)+ | Peak area | Case | Y | Exemestane | White | 3 Month | Y | Y | |
Reversed phase POSITIVE ION MODE | SEROTONIN (CAS# 50-67-9); (M+NA)+ | Peak area | Case | Y | Exemestane | White | Baseline | N | Y | |
Reversed phase POSITIVE ION MODE | SEROTONIN (CAS# 50-67-9); (M+NA)+ | Peak area | Case | Y | Exemestane | White | Baseline | Y | Y | |
Reversed phase POSITIVE ION MODE | SEROTONIN (CAS# 50-67-9); (M+NA)+ | Peak area | Case | Y | Letrozole | White | 3 Month | Y | Y | |
Reversed phase POSITIVE ION MODE | SEROTONIN (CAS# 50-67-9); (M+NA)+ | Peak area | Case | Y | Letrozole | White | Baseline | Y | Y | |
Reversed phase POSITIVE ION MODE | SEROTONIN (CAS# 50-67-9); (M+NA)+ | Peak area | Control | N | Exemestane | Black | 3 Month | Y | N | |
Reversed phase POSITIVE ION MODE | SEROTONIN (CAS# 50-67-9); (M+NA)+ | Peak area | Control | N | Exemestane | Black | Baseline | Y | N | |
Reversed phase POSITIVE ION MODE | SEROTONIN (CAS# 50-67-9); (M+NA)+ | Peak area | Control | N | Exemestane | White | 3 Month | N | N | |
Reversed phase POSITIVE ION MODE | SEROTONIN (CAS# 50-67-9); (M+NA)+ | Peak area | Control | N | Exemestane | White | 3 Month | Y | N | |
Reversed phase POSITIVE ION MODE | SEROTONIN (CAS# 50-67-9); (M+NA)+ | Peak area | Control | N | Exemestane | White | Baseline | N | N | |
Reversed phase POSITIVE ION MODE | SEROTONIN (CAS# 50-67-9); (M+NA)+ | Peak area | Control | N | Exemestane | White | Baseline | Y | N | |
Reversed phase POSITIVE ION MODE | SEROTONIN (CAS# 50-67-9); (M+NA)+ | Peak area | Control | N | Letrozole | Black | 3 Month | N | N | |
Reversed phase POSITIVE ION MODE | SEROTONIN (CAS# 50-67-9); (M+NA)+ | Peak area | Control | N | Letrozole | Black | Baseline | N | N | |
Reversed phase POSITIVE ION MODE | SEROTONIN (CAS# 50-67-9); (M+NA)+ | Peak area | Control | N | Letrozole | White | 3 Month | N | N | |
Reversed phase POSITIVE ION MODE | SEROTONIN (CAS# 50-67-9); (M+NA)+ | Peak area | Control | N | Letrozole | White | 3 Month | Y | N | |
Reversed phase POSITIVE ION MODE | SEROTONIN (CAS# 50-67-9); (M+NA)+ | Peak area | Control | N | Letrozole | White | Baseline | N | N | |
Reversed phase POSITIVE ION MODE | SEROTONIN (CAS# 50-67-9); (M+NA)+ | Peak area | Control | N | Letrozole | White | Baseline | Y | N | |
Reversed phase POSITIVE ION MODE | SEROTONIN (CAS# 50-67-9); (M+NA)+ | Peak area | Control | Y | Exemestane | White | 3 Month | N | N | |
Reversed phase POSITIVE ION MODE | SEROTONIN (CAS# 50-67-9); (M+NA)+ | Peak area | Control | Y | Exemestane | White | 3 Month | N | Y | |
Reversed phase POSITIVE ION MODE | SEROTONIN (CAS# 50-67-9); (M+NA)+ | Peak area | Control | Y | Exemestane | White | 3 Month | Y | N | |
Reversed phase POSITIVE ION MODE | SEROTONIN (CAS# 50-67-9); (M+NA)+ | Peak area | Control | Y | Exemestane | White | 3 Month | Y | Y | |
Reversed phase POSITIVE ION MODE | SEROTONIN (CAS# 50-67-9); (M+NA)+ | Peak area | Control | Y | Exemestane | White | Baseline | N | N | |
Reversed phase POSITIVE ION MODE | SEROTONIN (CAS# 50-67-9); (M+NA)+ | Peak area | Control | Y | Exemestane | White | Baseline | N | Y | |
Reversed phase POSITIVE ION MODE | SEROTONIN (CAS# 50-67-9); (M+NA)+ | Peak area | Control | Y | Exemestane | White | Baseline | Y | N | |
Reversed phase POSITIVE ION MODE | SEROTONIN (CAS# 50-67-9); (M+NA)+ | Peak area | Control | Y | Exemestane | White | Baseline | Y | Y | |
Reversed phase POSITIVE ION MODE | SEROTONIN (CAS# 50-67-9); (M+NA)+ | Peak area | Control | Y | Letrozole | White | 3 Month | Y | N | |
Reversed phase POSITIVE ION MODE | SEROTONIN (CAS# 50-67-9); (M+NA)+ | Peak area | Control | Y | Letrozole | White | 3 Month | Y | Y | |
Reversed phase POSITIVE ION MODE | SEROTONIN (CAS# 50-67-9); (M+NA)+ | Peak area | Control | Y | Letrozole | White | Baseline | Y | N | |
Reversed phase POSITIVE ION MODE | SEROTONIN (CAS# 50-67-9); (M+NA)+ | Peak area | Control | Y | Letrozole | White | Baseline | Y | Y |